Addressing AMR across the tightrope of politics, policy and practice

30 November – 1 December

QEII Centre, London and online

You can view the recorded content from this online conference below.

This conference is RCPath CPD accredited (10 credits).

Abstracts from this conference are now published and available to view open access here.

For all enquiries, please contact Esme Carruthers.

Programme

-
OPENING LECTURE
This video consists of the following presentations
-
Welcome and opening remarks
David Jenkins, University Hospitals of Leicester NHS Trust & BSAC President
-
Indication-wise antimicrobial management - bringing AwARE to life
Benedikt Huttner, Team Lead, Essential Medicines, World Health Organization

-
SESSION ONE: Clinical challenges
This video consists of the following presentations
-
Complex infective endocarditis
Jonathan Sandoe, Associate Professor, University of Leeds, Leeds Teaching Hospitals NHS Trust
-
New frontiers for complex UTIs
Angela Huttner, Infectious Disease Division, University Hospitals of Geneva
-
Candida auris - no longer an emerging problem
Tina Joshi, Associate Professor of Molecular Microbiology, University of Plymouth
-
Adeno-associated virus 2 infection in children with non-A–E hepatitis
Antonia Ho, Clinical Senior Lecturer, MRC-University of Glasgow Centre for Virus Research & Honorary Consultant in Infectious Diseases, NHS Greater Glasgow & Lanarkshire

-
SESSION TWO: Diagnostics - a critical lever for supporting National Action Plans?
This video consists of the following presentations
-
How do we assess and value rapid diagnostics?
Luke Moore, Consultant Infectious Diseases, Microbiology, & Virology, Chelsea & Westminster NHS Foundation Trust, Consultant Microbiology, North West London Pathology, Imperial College Healthcare NHS Trust, Honorary Clinical Senior Lecturer, Imperial College London
-
Optimising the role of blood cultures to drive effective prescribing decisions
Brigitte Lamy, Clinical microbiologist & Assistant professor, Université Sorbonne Paris Nord & Academic hospital of Avicenne (APHP, Paris)
-
Optimising the blood culture pathway – moving from nice to do so must do
Jane Freeman, Leeds Teaching Hospitals NHS Trust

-
SESSION FOUR: Free papers - Difficult to treat infections, antimicrobial alternatives & common clinical conundrums
This video consists of the following presentations
-
Impact of Dietary Habits on AMR Development in Human Gut Bacteria: Insights from a Hollow Fiber Infection Model
Jegak Seo, PhD Student, University College London
-
Epidemiology and Clinical Characteristics of Patients with Carbapenem-Resistant Enterobacterales Infections: Experience from a Large Tertiary Care Center in a Developing Country
Banan Aiesh, National University Hospital, Palestine
-
Reintroducing Pen and Leaving Quin-Alone
Lisa Duffy, ID Registrar, University Hospital Galway
-
Antimicrobial susceptibility to last-resort antibiotics in carbapenemase-producing bacteria from Ukrainian patients
Nelianne Verkaik, Erasmus University Medical Center, Rotterdam

-
SESSION FIVE: Panel discussion - The impact of conflict and natural disaster on AMR
This video consists of the following presentations
-
Scene setting
David Jenkins, University Hospitals of Leicester NHS Trust
-
Panel discussion
Panellists:
Clare Shortall, MSF
Mark Koziol, Pharmacists' Defence Association (PDA)
Shehan Hettiaratchy, UK-MED
-
Day One closing remarks
David Jenkins, University Hospitals of Leicester NHS Trust
-
SESSION SIX: Interpreting EUCAST guidance
This video consists of the following presentations
-
BSAC Guidance on aminopenicillin BP changes
Robin Howe, Director of Infection Services, Public Health Wales Microbiology
-
What to do when there are no BPs; recent new EUCAST guidance
Pegah Hafezi, AST & AMR lead, Bristol
-
Interpreting fosfomycin breakpoints: a recent EUCAST consultation
Alasdair MacGowan, Consultant in Infection, North Bristol NHS Trust & Professor of Antimicrobial Therapeutics, University of Bristol

-
SESSION SEVEN: Conflict and crisis - how do we prevent, contain and manage MDR infections?
This video consists of the following presentations
-
Communicable diseases and AMR post-earthquakes
Aula Abbara, Consultant in Clinical Infectious Diseases/General Internal Medicine & Honorary Senior Clinical Lecturer in Infection, Imperial College
-
Management of microbiology in conflict and crisis situations
Scott Pallett, ST5 Microbiology & Infectious Diseases Defence Medical Services, Frimley Park Hospital

-
SESSION NINE: Garrod Lecture
-
Antibiotic use and antimicrobial stewardship in primary care: what works, and what next?
Paul Little, Professor of Primary Care Research, University of Southampton

-
SESSION ELEVEN: Forecasting the future of infectious disease management
-
Artificial Intelligence - the answer to our research dreams?
Autumn Gertz, Project Manager, Computational Epidemiology Lab, Boston Children’s Hospital & Harvard Medical School
-
Reducing global MDR infections through the WASH agenda
Dennis Lupenga, Senior Voices from the Field officer, WaterAid
-
The supply chain crisis - problem and potential solutions
Liz Breen, Director of the Digital Health Enterprise Zone (DHEZ) & Professor of Health Service Operations, University of Bradford
-
Microbiotoxicity: a plea from your patient’s microbiome
Anastasia Theodosiou, MRC Clinical Research Training Fellow (University of Southampton) & Infectious Diseases & Medical Microbiology Registrar
-
Closing remarks
David Jenkins, University Hospitals of Leicester NHS Trust & BSAC President

Having trouble finding what you're after?

Top